Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cardiac catheterisation and coronary angiography

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Activate immediate invasive management for STEMI and for NSTE-ACS with haemodynamic instability, recurrent or refractory pain, life-threatening arrhythmia or acute heart failure; stabilisation and transfer should occur in parallel.

Synopsis

Use invasive angiography and haemodynamic catheterisation when results will change treatment, while reducing access, bleeding, kidney and radiation harm.

  • Coronary angiography defines lumen anatomy but does not show plaque biology or prove that an intermediate stenosis causes ischaemia.
  • Use FFR or a validated non-hyperaemic pressure ratio to assess intermediate lesions before revascularisation when functional significance is uncertain.
  • Radial access usually reduces access-site bleeding and permits earlier mobilisation, but anatomy and procedure may require femoral access.
  • Before the procedure review indication, alternatives, consent, renal function, blood count, coagulation, allergies and all antithrombotic medicines.
  • Right-heart catheterisation measures pressures, cardiac output and shunt data when non-invasive assessment is insufficient for a decision.
  • New chest or back pain, hypotension, neurological deficit, limb ischaemia or enlarging access swelling after catheterisation is an emergency.
  • A normal angiogram in a patient with angina can redirect assessment toward vasospasm or microvascular dysfunction rather than proving symptoms are non-cardiac.

Key red flags

Coronary occlusion

Acute occlusion with an ACS presentation requires immediate reperfusion strategy and antithrombotic management.

Access-site bleeding

Persistent bleeding, expanding haematoma, hypotension or falling haemoglobin requires compression, resuscitation and urgent vascular assessment.

Retroperitoneal haemorrhage

Back or flank pain, hypotension and unexplained anaemia after femoral access may occur without obvious groin swelling.

Contrast-associated or embolic complication

Oliguria, acute neurological deficit, coronary dissection, no-reflow or limb ischaemia requires prompt targeted escalation.

Investigation priorities

01
Invasive coronary angiographyFirst step

Define coronary anatomy and enable revascularisation in appropriate ACS or chronic coronary syndromes.

Management branches

Preferred routeChronic coronary syndrome

Severe refractory symptoms, high event risk or high pre/post-test likelihood

  1. Confirm the indication, optimise guideline-directed therapy and review non-invasive anatomy or ischaemia.
  2. Obtain informed consent covering diagnostic angiography, possible PCI, CABG alternative and material risks.
  3. Perform angiography with radial access when suitable and use invasive physiology for intermediate stenoses.
  4. Use shared or Heart Team decision-making for complex anatomy and document the prevention plan regardless of revascularisation.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG95: Recent-onset chest pain
  • NICE NG185: Acute coronary syndromes
  • ESC 2024 Guidelines for chronic coronary syndromes
  • ESC 2023 Guidelines for acute coronary syndromes

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom